Fact check: NIH continues to recommend against using ivermectin as a COVID-19 treatment




  • In Health
  • 2022-09-15 00:16:00Z
  • By USA TODAY

The claim: The National Institutes of Health added ivermectin to its list of COVID-19 treatments

Medical experts have repeatedly debunked claims that ivermectin, an anti-parasitic drug used primarily for farm animals, can treat COVID-19.

Nevertheless, the assertion that ivermectin is an effective COVID-19 treatment continues to circulate on social media, especially among those who are not vaccinated, and now some are arguing the drug has been endorsed by federal health officials.

"Yesterday, the National institute (sic) of health added Ivermectin to the list of covid (sic) treatment," reads a Sept. 1 tweet shared by Jake Shields, a professional mixed martial artist. "Looks like the conspiracy theorist (sic) were right and the 'experts' wrong (sic) once again."

Jesse Kelly, a conservative radio host, re-tweeted  the claim, adding, "Remember when the FDA called Ivermectin 'horse dewormer' and pharmacies refused to fulfill doctor prescriptions for it?"

A screenshot of Kelly's tweet was shared on Instagram, where it garnered over 700 likes in less than a week. All together, Shields' and Kelly's tweets amassed over 64,000 likes.

But the claim is baseless.

The National Institutes of Health does not recommend ivermectin as a COVID-19 treatment, according to the agency's website. There is no evidence the agency recently changed its stance on ivermectin.

USA TODAY reached out to Shields, Kelly and the social media users who shared the claim for comment.

A box of ivermectin is shown in a pharmacy as pharmacists work in the background, Thursday, Sept.
A box of ivermectin is shown in a pharmacy as pharmacists work in the background, Thursday, Sept.  

Agency has not changed its position on ivermectin

Ivermectin is included in the COVID-19 treatment guidelines section of the National Institutes of Health's website, and it is labeled an anti-parasitic drug that is "being evaluated to treat COVID-19." It has been in the treatment guidelines section for over a year, according to an archive.

The agency last updated its guidance on ivermectin in April and "recommends against the use of ivermectin for the treatment of COVID-19, except in clinical trials." There have been no recent changes to the guidance, according to USA TODAY's analysis of archived pages.

The recommendation was primarily based on published, randomized controlled trials that showed "the use of ivermectin for the treatment of COVID-19 had no clinical benefit," according to the agency's website.

When contacted for comment, the National Institutes of Health referred USA TODAY to its website.

Fact check: Baseless conspiracy theory about monkeypox, Pfizer COVID-19 vaccine and 'Great Reset'

Both the Food and Drug Administration and the World Health Organization have also recommended against the use of ivermectin to treat COVID-19, as USA TODAY previously reported.

The FDA has either approved or given emergency-use authorizations to only a few drugs for the treatment of COVID-19, including remdesivir and molnupiravir, according to the National Institutes of Health.

PolitiFact and the Associated Press have also debunked the claim.

Our rating: False

Based on our research, we rate FALSE the claim that the National Institutes of Health added ivermectin to its list of COVID-19 treatments. The federal agency does not recommend ivermectin as a COVID-19 treatment, according to its website. The agency has not made any recent updates regarding ivermectin.

Our fact-check sources:

Thank you for supporting our journalism. You can subscribe to our print edition, ad-free app or electronic newspaper replica here.

Our fact-check work is supported in part by a grant from Facebook.

This article originally appeared on USA TODAY: Fact check: NIH recommends against ivermectin as a COVID-19 treatment

COMMENTS

More Related News

WHO pleased to see China ease harsh zero COVID policies
WHO pleased to see China ease harsh zero COVID policies
  • US
  • 2022-12-02 15:27:04Z

A top official at the World Health Organization said the U.N. agency was "pleased" to see China loosening some of its coronavirus restrictions, saying "it's ...

Asian shares tentative ahead of U.S. payrolls data, dollar nurses losses
Asian shares tentative ahead of U.S. payrolls data, dollar nurses losses

Asian shares were flat and Treasuries held onto gains on Friday ahead of the U.S. non-farm payrolls data, the next big test for investors looking for more...

China eases virus controls amid effort to head off protests
China eases virus controls amid effort to head off protests
  • World
  • 2022-12-01 08:35:59Z

More Chinese cities eased anti-virus restrictions and police patrolled their streets Thursday as the government tried to defuse public anger over some of the...

Chinese vaccine plans spark hope for end of
Chinese vaccine plans spark hope for end of 'zero COVID'
  • World
  • 2022-11-30 09:31:50Z

A campaign to vaccinate the elderly has sparked hopes China might roll back severe anti-virus controls that prompted protesters to demand President Xi...

Asia stocks choppy as investors cautious after disappointing China data
Asia stocks choppy as investors cautious after disappointing China data

Asian shares wobbled on Wednesday as investors remain cautious about China's path to reopening its economy after it released disappointing manufacturing data...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Health